WOW Health combines a 24/7 online health platform with a national directory of WOW providers and local access to “It’s How You Live” events and experiences.
The company’s memantine hydrochloride tablets, available in 5- and 10-mg dosage strengths, are meant to treat dementia associated with Alzheimer’s disease.
The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.
In order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and support.
According to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4% of the population) live with substance use disorders.
A new World Health Organization report amid the largest outbreak of Ebola ever recorded describes “a promising Ebola vaccine candidate,” identified by a trial in Guinea.
According to IRI, sales of Goody's analgesics and Monistat 1 are doing extremely well, with annualized sales of $38.7 million (up 4.8%) and $49.2 million (up 5.4%), respectively.
Aurobindo Pharma Limited on Tuesday received approval from the Food and Drug Administration for its alprazolam tablets, a generic version of Xanax.
Mylan on Wednesday announced the U.S. launch of its generic version of Nexium (esomeprazole magnesium delayed-release capsules) in 20- and 40-mg dosage strengths.
The FDA and industry have been working together to make liquid formulations of acetaminophen safer for children.